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Abstract
Intracellular pathogens have evolved diverse strategies to invade and survive within host cells. Among the most studied
facultative intracellular pathogens, Listeria monocytogenes is known to express two invasins-InlA and InlB-that induce
bacterial internalization into nonphagocytic cells. The pore-forming toxin listeriolysin O (LLO) facilitates bacterial escape
from the internalization vesicle into the cytoplasm, where bacteria divide and undergo cell-to-cell spreading via actin-based
motility. In the present study we demonstrate that in addition to InlA and InlB, LLO is required for efficient internalization of
L. monocytogenes into human hepatocytes (HepG2). Surprisingly, LLO is an invasion factor sufficient to induce the
internalization of noninvasive Listeria innocua or polystyrene beads into host cells in a dose-dependent fashion and at the
concentrations produced by L. monocytogenes. To elucidate the mechanisms underlying LLO-induced bacterial entry, we
constructed novel LLO derivatives locked at different stages of the toxin assembly on host membranes. We found that LLO-
induced bacterial or bead entry only occurs upon LLO pore formation. Scanning electron and fluorescence microscopy
studies show that LLO-coated beads stimulate the formation of membrane extensions that ingest the beads into an early
endosomal compartment. This LLO-induced internalization pathway is dynamin-and F-actin-dependent, and clathrin-
independent. Interestingly, further linking pore formation to bacteria/bead uptake, LLO induces F-actin polymerization in a
tyrosine kinase-and pore-dependent fashion. In conclusion, we demonstrate for the first time that a bacterial pathogen
perforates the host cell plasma membrane as a strategy to activate the endocytic machinery and gain entry into the host
cell.
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Introduction
Despite the diversity of virulence factors promoting host cell
invasion, only two major mechanisms of entry have been observed
[1–3]. First, invasins on the bacterial cell surface bind to host cell
receptors to activate complex signaling cascades that orchestrate
the internalization of the bacterium. Second, some bacteria bypass
the requirement for a host receptor by utilizing a secretion system
that injects effectors into the host cell. The effectors subvert the
host signaling machinery to trigger bacterial uptake into macro-
pinosomes [4,5]. Using Listeria monocytogenes as a model intracellular
pathogen, we have analyzed a novel entry pathway that is
activated in response to host cell perforation by a pore-forming
toxin.
L. monocytogenes is a foodborne pathogen that causes a large
spectrum of clinical manifestations ranging from gastroenteritis to
life-threatening meningo-encephalitis and sepsis. Susceptible hosts
include the elderly and immunocompromised individuals [6]. In
pregnant women, the bacterium can cross the maternofetal barrier
causing abortion, stillbirth, and neonatal meningitis or sepsis [6–
8]. To cross the host barriers and infect various organs including
the liver [9–12], L. monocytogenes expresses multiple virulence
factors that induce its entry and survival into various nonphago-
cytic cells [13–16].
Two major genetic loci encode the virulence factors responsible
for host cell invasion: the internalin operon and Listeria
pathogenicity island 1 (LIPI-1) [17,18]. The internalin operon
encodes internalin (InlA) and InlB that bind to E-cadherin and the
hepatocyte growth factor receptor (HGF-Rc/c-Met), respectively
[19,20]. Depending on the receptors expressed by the host cells, L.
monocytogenes entry involves one or both internalins [21,22]. The
internalin/host receptor interactions activate signaling cascades
within cholesterol-rich microdomains leading to the internalization
of the bacterium [23–26]. After internalization, the secreted pore-
forming toxin listeriolysin O (LLO) and two phospholipases
(encoded by LIPI-1) mediate L. monocytogenes escape from the
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undergo F-actin based motility to spread from cell to cell [27–29].
InlA and InlB were defined as bacterial invasins based upon
their critical role in L. monocytogenes invasion of nonphagocytic cells,
and the fact that they are sufficient to induce entry of noninvasive
bacteria when overexpressed from a plasmid [17,30]. It is well
established that the internalins are critical for host cell invasion;
however, they may not be sufficient for inducing efficient bacterial
uptake due to their low levels of expression in L. monocytogenes.
Additional virulence factors including LLO have been proposed to
regulate L. monocytogenes entry into host cells [31–35].
LLO is required for L. monocytogenes pathogenesis [36] and
belongs to the family of the cholesterol-dependent cytolysins
(CDCs) produced by numerous Gram-positive pathogens [37–39].
The CDCs are 50–70 kDa proteins synthesized as water soluble
monomers that bind to cholesterol in host cell membranes [40].
Three members of the CDCs, intermedilysin, lectinolysin and
vaginolysin, have been shown to bind to a host receptor (the
complement regulatory molecule CD59) in addition to cholesterol
[41–43]. Upon binding to host membranes, the CDCs diffuse
laterally to form a ring-shaped oligomeric prepore complex. This
complex then inserts a large b-barrel pore across the membrane in
a cholesterol-dependent fashion [44]. Eukaryotic cells possess
sophisticated mechanisms to repair damaged plasma membranes
and survive moderate exposure to pore-forming toxins including
the CDCs [45]. A growing body of evidence demonstrates that
pores formed by pore-forming proteins including perforin, S. aureus
alpha hemolysin, and the CDC streptolysin O (SLO), are removed
from the plasma membrane through a mechanism that involves
membrane internalization [45–47]. The ability of CDCs to induce
membrane internalization in eukaryotic cells to repair their
membrane raised the hypothesis that LLO may affect the
internalization of L. monocytogenes. In the present work we explored
the link between the formation of pore complexes by LLO and
bacterial internalization. Using several experimental approaches,
we determined that LLO is a critical invasion factor that perforates
the host cell plasma membrane to activate L. monocytogenes
internalization into human hepatocytes.
Results
LLO is critical for efficient entry of L. monocytogenes into
host cells
The gentamicin survival assay is commonly used to assess the
role of virulence factors in the intracellular survival of bacterial
pathogens. This assay enumerates viable intracellular bacteria
after killing extracellular bacteria with the cell impermeant
antibiotic gentamicin. We measured the relative intracellular
survival of wild type L. monocytogenes (WT), along with an isogenic
LLO-deficient (Dhly) mutant, a double deletion mutant deficient in
the expression of InlA and InlB (DinlAB), a triple deletion mutant
(DhlyDinlAB), and the LLO-complemented mutant (Dhly +
pAM401hly and DhlyDinlAB + pAM401hly) strains in HepG2 cells.
As presented in Fig. 1A, efficient intracellular survival of L.
monocytogenes required the expression of the internalins as well as
LLO. In the absence of the three virulence factors, intracellular
survival was almost completely abrogated. The defect in
intracellular survival of LLO-deficient bacteria (Dhly) was due to
the lack of LLO expression, as the LLO-complemented (Dhly +
pAM401hly) and WT strains displayed similar intracellular
survival.
The results obtained with the gentamicin assay reflect the
efficiencies of several stages of host cell invasion including L.
monocytogenes association with host cells, entry into host cells, escape
from the internalization vesicle, and intracellular division. LLO is
known to promote L. monocytogenes intracellular survival by
mediating bacterial escape from the internalization vesicle;
therefore, it was difficult to dissociate the role of LLO in escape
from its potential role in bacterial association and/or entry using
this assay. To specifically assess the role of LLO during the initial
stages of the invasion process, we used an automated fluorescence-
based assay that measures the efficiencies of bacterial association
with and internalization into host cells [48]. We found that LLO
and the internalins did not significantly affect bacterial association
with HepG2 cells. However, LLO significantly increased bacterial
association when overexpressed from a plasmid (Fig. 1C). More
importantly, LLO is critical for L. monocytogenes internalization as
we observed a marked decrease in entry of the LLO (Dhly) and
LLO/internalins (DhlyDinlAB) deficient strains relative to the WT
strain (Fig. 1D). The LLO-complemented (Dhly + pAM401hly) and
WT strains displayed similar internalization efficiencies (Fig. 1D).
We also tested a second strain of L. monocytogenes (LO28) and its
isogenic LLO-deficient mutant (LO28 hly::Tn917) and the human
epithelial HeLa cells that are commonly used as a model to study
the L. monocytogenes intracellular lifecycle. Again, we found that
LLO is a key virulence factor that controls bacterial entry into host
cells but does not significantly affect bacterial association with host
cells (Fig. S1).
Direct and dose-dependent activity of LLO in L.
monocytogenes entry into host cells
The lack of LLO in the LLO-deficient strains may indirectly
decrease the efficiency of bacterial entry by affecting the
expression or regulation of other virulence factors. To verify that
the defect in entry was solely due to the absence of LLO, we used
LLO-deficient bacteria coated with increasing concentrations of
six-His tagged recombinant LLO. LLO was noncovalently
adsorbed on the surface of LLO-deficient L. monocytogenes using a
previously described protocol [49]. We performed a noncovalent
coating because the toxin monomers likely need to dissociate from
the bacterial surface to freely diffuse within the host cell membrane
and form oligomers and pores. To validate the coating procedure,
we measured the fluorescence intensity of bacteria coated with
Author Summary
Listeria monocytogenes is responsible for the severe
foodborne disease listeriosis. During pathogenesis, inva-
sion of nonphagocytic cells by L. monocytogenes is crucial
for crossing the host epithelial barriers and colonization of
multiple organs including the liver. In this study, we
investigated the role of the pore-forming toxin listeriolysin
O (LLO) in L. monocytogenes entry into human hepato-
cytes. LLO belongs to the largest family of bacterial pore-
forming toxins called the cholesterol-dependent cytolysins
and is a major virulence factor of L. monocytogenes.W e
observed that LLO is required for efficient entry of L.
monocytogenes into hepatocytes and shed light on the
molecular processes involved in this activity. Using
different experimental approaches, we provide the first
evidence that LLO is sufficient to induce bacterial
internalization into host cells by a pore-dependent
mechanism. LLO induces tyrosine kinase(s)-, dynamin-,
and F-actin-dependent formation of an internalization
vesicle. Similar to LLO, the pore-forming toxin pneumoly-
sin regulates bacterial entry into host cells. Together, these
findings indicate that host membrane perforation by a
pore-forming toxin can be used as an invasion strategy by
L. monocytogenes and raise the hypothesis that other
bacteria may use a similar entry pathway.
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S2). We then measured the entry of LLO-deficient L. monocytogenes
coated with increasing concentrations of recombinant LLO and
observed that LLO increased bacterial entry into HepG2 cells in a
dose-dependent fashion (Fig. 2A). We next determined whether
LLO should be localized in the vicinity of the bacteria or whether
LLO could act distally to regulate entry. When adding LLO to the
culture medium along with the LLO-deficient strain, we observed
an increase in the efficiency of bacterial internalization (Fig. 2B).
Together, these data show that LLO potentiates internalization of
L. monocytogenes into host cells in a dose-dependent fashion by
acting locally or from a distance.
Figure 1. LLO is required for efficient entry of L. monocytogenes into HepG2 cells. (A) HepG2 cells were infected with isogenic WT
(DP10403S), LLO-deficient (Dhly), InlAB-deficient (DinlAB), LLO- and InlAB-deficient (DhlyDinlAB), or LLO-complemented (Dhly + pAM401hly;
DhlyDinlAB +pAM401hly) bacteria (MOI=20) for 30 min at 37uC. Gentamicin was added for 1 h and the CFUs were enumerated as described in
methods. Results were the mean 6 SEM (n$3) and expressed relative to WT. Statistics indicated here and elsewhere are as follows: * p,0.05;
** p,0.005. (B)t o( D) Cells were infected with WT, LLO-deficient (Dhly), LLO- and InlAB-deficient (DhlyDinlAB), or LLO-complemented (Dhly +
pAM401hly; DhlyDinlAB + pAM401hly) bacteria (MOI=20) for 30 min at 37uC. Cells were washed, fixed, and labeled with fluorescent antibodies and
DAPI. (B) Representative images of WT extracellular bacteria (green), total bacteria (red), and HepG2 nuclei (blue). The arrow indicates an internalized
bacterium. Scale bar=10 mm. In (C) and (D), results were the mean 6 SEM (n$3) and were expressed relative to WT.
doi:10.1371/journal.ppat.1002356.g001
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host cells
We determined whether LLO is sufficient to induce bacterial
entry into host cells or whether it only potentiates the internalins’
activity. We used nonpathogenic and noninvasive Listeria innocua
that does not express any of the known L. monocytogenes virulence
factors [50]. As shown in Fig. 3A, L. innocua noncovalently coated
with six-His tagged LLO were able to enter and survive in HepG2
cells. As a second approach, L. innocua were transformed with a
plasmid coding for hly (L. innocua phly/prfA*). As presented in
Fig. 3B, LLO secreted from L. innocua phly/prfA* was sufficient to
induce bacterial entry and survival into HepG2 cells. The
efficiency of host cell invasion by L. innocua phly/prfA* was low
compared to what was observed with WT L. monocytogenes and
LLO-coated L. innocua (Fig. 3A). Because the activity of LLO in
bacterial entry is dose-dependent (Fig. 2), we determined whether
L. innocua phly/prfA* expresses low levels of LLO compared to WT
L. monocytogenes. The hemolytic activity of L. innocua phly/prfA* was
approximately 40-fold lower than L. monocytogenes (Fig. 3C). L.
innocua phly/prfA* also produced low levels of LLO compared with
WT L. monocytogenes (Fig. 3D). These results demonstrate that low
concentrations of LLO (below the concentration secreted by L.
monocytogenes) are sufficient to induce bacterial entry into host cells.
To assess the role of LLO in the absence of any other bacterial
factor, we measured the uptake of 1 mm fluorescent polystyrene
beads coated with LLO. The beads were first covalently coated
with bovine serum albumin (BSA). The BSA-coated beads were
then noncovalently coated with LLO [49]. LLO was sufficient to
induce internalization of the beads into HepG2 cells in a dose-
dependent fashion; whereas, the beads coated with only BSA were
not taken up by the cells (Fig. 4A and B). This result clearly
showed for the first time that a pore-forming toxin is a bacterial
invasion factor. Cell viability was assessed by measuring the release
of lactate dehydrogenase (LDH) and by trypan blue exclusion
immediately and 24 h following toxin treatment (Fig. S3). These
results show that the concentrations of LLO that lead to the
optimal bead uptake by host cells do not compromise cellular
integrity.
LLO perforates host cells at physiological temperature
and pH
Previous studies have established that pore-formation by LLO is
pH sensitive at the host temperature (37uC), with LLO being more
active at acidic pH. At 37uC, soluble LLO is inactivated by a pH-
triggered unfurling of the domain 3 twin a-helical bundles that
prevents further formation of a pore [51]. We hypothesized that
the pH and temperature dependent inactivation would not occur if
LLO was incubated in the presence of host membranes.
Presumably, LLO would bind to the cell membrane where it
would assemble into functional pores rather than unfolding in a
nonproductive fashion. This hypothesis was based upon the
observation that LLO is active when added to a solution of
erythrocytes at 37uC and neutral pH (all of our hemolytic assays
were carried out at 37uC, pH 7.4). To test this hypothesis, we pre-
incubated LLO for 20 min in the absence of host cell membranes
(in PBS at 37uC, pH 7.4 or 5.5) before performing the hemolytic
analysis at 37uC (pH 7.4 or 5.5). Consistent with the previous
observation of Schuerch et al. [51], pre-incubating the toxin at
neutral pH and 37uC inactivated LLO; whereas, at acidic pH
some activity of the toxin was retained (Fig. 5A). If, however LLO
Figure 2. Direct and dose-dependent role of LLO in L. monocytogenes entry. (A) LLO-deficient L. monocytogenes (Dhly, strain DPL2161, L.m.)
treated with 1 mM nickel (II) chloride coating buffer in the absence (C) or presence of LLO (black bars) or LLO Alexa 488 (grey bar) were used to infect
HepG2 cells at 37uC for 30 min (MOI=20). (B) HepG2 cells were infected with LLO-deficient L. monocytogenes (Dhly, DPL2161) at 37uC for 30 min
(MOI=20), in the absence (C) or in the presence of LLO added exogenously to the cell culture medium (black bars). In (A) and (B) bacterial entry was
measured by fluorescence microscopy. The results were expressed relative to bacteria incubated with host cells in the absence of LLO (C) and were
the mean 6 SEM (n$3).
doi:10.1371/journal.ppat.1002356.g002
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hemolytic assay at 37uC, LLO retained its activity at pH 7.4 and
5.5 (Fig. 5B). These data show that soluble monomers of LLO are
inactivated at 37uC and pH 7.4 in the absence of membrane, but
in the presence of membranes LLO can rapidly bind to the
membrane and form pores.
In response to membrane perforation by pore-forming toxins,
host cells reseal their membranes using a repair process that is
activated upon the influx of extracellular calcium [45]. To further
demonstrate that low concentrations of LLO efficiently perforate
HepG2 cells at physiological temperature and pH, we measured
host cell perforation in the presence and absence of extracellular
calcium. Membrane perforation was quantified by fluorescence
imaging using the membrane impermeant dye ethidium homodi-
mer. In solution this dye is weakly fluorescent, but once host cells
are perforated, it enters the cells and associates with nucleic acids,
which increases its fluorescence quantum yield. As shown in
Fig. 5C and D, a baseline level of fluorescence was detected with
host cells exposed to ethidium homodimer in calcium-free buffer at
37uC, pH 7.4 (Videos S1 and S2). LLO induces a massive entry of
ethidium homodimer into cells incubated in calcium-free buffer
(Videos S3 and S4), but not in the presence of 1 mM extracellular
calcium. The extensive perforation of host cells was not due to the
toxicity of ethidium homodimer, as in its absence LLO induces cell
swelling and lysis with similar kinetics (Video S5). In total, these
results showed that at 37uC, extracellular LLO efficiently
perforates host cells at neutral pH.
Construction and characterization of novel LLO variants
unable to form pores
To determine the importance of toxin oligomerization and pore
formation in LLO-induced bacterial and bead entry into host cells,
we constructed LLO derivatives locked at different stages of the
pore-forming mechanism. Studies performed with the CDC
perfringolysin O showed that the introduction of two cysteines at
Figure 3. LLO is sufficient to induce the entry of noninvasive L. innocua into HepG2 cells. (A) HepG2 cells were infected with WT L.
monocytogenes (DP10403S, L.m.), L. innocua (L.i.),o rL. innocua treated with 1 mM nickel (II) chloride coating buffer in the absence (L.i. buffer) or
presence of 5 mM LLO (L.i. buffer + LLO) at MOI=20 for 30 min at 37uC. Gentamicin was added for 1 h and the intracellular CFUs were enumerated.
Results were the mean 6 SEM (n$3) and expressed relative to L. monocytogenes.( B) HepG2 cells were infected with L. innocua (L.i.)o rL. innocua phly/
prfA*( L.i. phly/prfA*) for 60 min at 37uC (MOI=100). Gentamicin was added for 30 min and the intracellular CFUs were enumerated. Results were the
mean 6 SEM (n$3) and expressed relative to L. i. phly/prfA*. (C) Hemolytic activities of L. monocytogenes (DP10403S) and L. innocua phly/prfA*
measured at 37uC for 30 min, pH 7.4. Results were the mean 6 SEM (n$3). (D) Equivalent amounts of L. monocytogenes and L. innocua lysates and
proteins precipitated from their culture supernatants were analyzed by western blotting using an anti-LLO primary antibody. A representative
experiment (of 3) is presented.
doi:10.1371/journal.ppat.1002356.g003
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the hemolytic activity of the toxin [52,53]. Depending on its
location, the disulfide bond impedes the conformational remodeling
required for formation of oligomers and/or pores, while toxin
binding to host membranes is unchanged [52]. Based on these
studies, we constructed and characterized LLOmL (monomer-
locked) and LLOpL (prepore-locked). LLOmL was expected to
bind to host membranes as a monomer unable to rearrange into a
prepore complex. LLOpL was expected to bind to host membranes
and oligomerize to form a stable prepore complex that cannot
undergo the final transition into a pore. Neither mutant exhibited
detectable hemolytic activity up to concentrations of 50 mM (higher
concentrations were not tested). The loss of activity was due to the
formation of the disulfide bonds, as reduction by dithiothreitol
(DTT) fully restored the native hemolytic activity of the toxins
(Fig.6A).Wenextdeterminedthe oligomerizationstate ofthetoxins
associated with erythrocyte membranes. As expected, LLO and
LLOpL formed detergent-resistant high molecular weight com-
plexes, whereas LLOmL failed to form such oligomers (Fig. 6B).
Importantly, the addition of DTT unlocked LLOmL, as shown by
the formation of detergent-resistant high molecular weight
oligomers. Finally, the arrangement of the toxins associated with
cholesterol-rich lipid layers was analyzed by transmission electron
microscopy (Fig. 6C). LLO and LLOpL formed characteristic arc-
and ring-shaped oligomers with a diameter of ,50 nm in the
presence and absence of DTT. LLOmL formed short linear
assemblies that may be representative of the early stages of toxin
oligomerization before formation of the prepore complex. Impor-
tantly, LLOmL formed the typical arc- and ring-shaped oligomers
when it was reduced by DTT.
LLO-induced bacterial and bead entry requires host cell
membrane perforation
WedeterminedtheroleofLLO oligomerizationinto preporeand
pore complexes in bacterial and bead entry into HepG2 cells.
Native LLO induced bacterial and bead internalization, whereas
neither LLOmL- nor LLOpL-coated beads were taken up by the
cells (Fig.7A and B) even though all three bind to host cells with
similar efficiency (Fig. 7C). We also used anti-LLO neutralizing
antibodies, which were previously shown to prevent formation of
LLOpores[54], toblock LLO-mediated uptakeofbeads.TheLLO
neutralizing antibodies markedly inhibited LLO hemolytic activity
and bead internalization, whereas control anti-LLO antibodies did
not (Fig. 7D and E). The prepore to pore conversion of the CDCs is
known to require high concentrations of membrane cholesterol
[55]. We therefore prevented the formation of membrane pores by
depleting host cholesterol using the cholesterol chelating agent
methyl b-cyclodextrin (MbCD). Cholesterol depletion completely
abrogatedLLO-inducedhostcellperforation andthe entryofBSA/
LLO-coated beads into HepG2 cells (Fig. 7F and G). To
demonstrate that inhibition of bead entry and host cell perforation
was specifically due to cholesterol depletion and not to a secondary
effect of the MbCD, we show that cholesterol repletion restored
bead uptake and membrane perforation by LLO (Fig. 7F and G).
We also observed that BSA/LLO-coated beads formed pores in
host cell membranes as detected by propidium iodide incorpora-
tion (Fig. S4A and B). Membrane perforation is a key event in
LLO-induced entry. Therefore, we hypothesized that a heterol-
ogous CDC should also increase L. monocytogenes internalization.
LLO-deficient L. monocytogenes were coated with recombinant six-
His tagged pneumolysin (PLY), the CDC produced by Streptococcus
pneumoniae [56] that exhibited a similar hemolytic activity to LLO
(Fig. S5A). Like LLO, PLY was able to mediate L. monocytogenes
entry into HepG2 cells (Fig. S5B). These data suggested that the
LLO structure did not contain unique features that were required
to induce bacterial invasion.
LLO activates a clathrin-independent, but dynamin-
dependent internalization pathway
To demonstrate that host cell perforation by LLO leads to the
formation of a micron sized internalization vesicle, we analyzed
Figure 4. LLO is sufficient to induce entry of polystyrene beads
into HepG2 cells. HepG2 cells were incubated with BSA- or BSA/LLO-
coated beads for 30 min at 37uC (MOI=20). Cells were washed, fixed,
and extracellular beads were fluorescently labeled with a primary anti-
BSA antibody and a secondary fluorescent antibody. (A) Representative
fluorescence and phase-contrast (PC) images acquired with a 100 X
objective. Scale bar=10 mm. (B) The mean 6 SEM (n$3) percentage of
intracellular beads was determined by counting a minimum of 100
beads in each sample.
doi:10.1371/journal.ppat.1002356.g004
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electron microscopy images showed the formation of plasma
membrane extensions entrapping the BSA/LLO-coated beads
after 15 min at 37uC. Within 30 min, we observed an increase in
the number of beads completely enveloped by the plasma
membrane (Fig. 8A), whereas, the formation of membrane
Figure 5. Extracellular LLO perforates erythrocytes and HepG2 cells at 37uC, pH 7.4. LLO was diluted in PBS pH 7.4 or 5.5 at 4uCi na9 6
well plate (20 ml toxin in each well). (A) The plate was incubated at 37uC for 20 min, then, 180 mlo fa3 7 uC suspension of sheep erythrocytes (0.25%)
in PBS pH 7.4 or 5.5 was added to each well. (B) The plate was kept on ice for 20 min, then, 180 mlo fa3 7 uC suspension of erythrocytes (0.25%) in PBS
pH 7.4 or 5.5 was added to each well. In (A) and (B) following addition of erythrocytes, the plates were incubated at 37uC in a Power Wave 340
spectrophotometer (Bio-Tek) and absorbance (700 nm) was acquired every min [102]. Results show representative experiments (of 3), each
performed in duplicate. In (C) and (D), perforation of HepG2 cells was measured by quantitative live cell fluorescence microscopy. HepG2 cells were
incubated on the microscope stage at 37uC for 40 min with ethidium homodimer and in the presence or absence of 1 mM calcium. Phase contrast
and fluorescence images were recorded at regular time intervals using a 100X objective and LLO was added after 10 min of incubation. Results were
expressed as the averagefluorescence intensity (in arbitrary units) in the cells 6 SEM of 5 movies for each condition. Scale bar=10 mm.
doi:10.1371/journal.ppat.1002356.g005
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demonstrate that LLO induces entry of BSA/LLO-coated beads
within a membrane-bound internalization vesicle, we quantified
intracellular beads that colocalize with the early endosomal
marker EEA1. After 30 min at 37uC, we observed that a large
population of intracellular beads was localized in endosomes to
which the EEA1 marker had been recruited (Figs. 8B and C). We
further characterized the endocytic molecules involved in this
pathway. We measured the entry of BSA/LLO-coated beads in
cells transfected with clathrin heavy chain silencing RNA and in
cells treated with the clathrin inhibitor chlorpromazine, or with
dynasore, a dynamin inhibitor (Fig. 9A and B). The uptake of
fluorescent transferrin was measured as a control for the inhibition
of clathrin- and dynamin-dependent endocytosis (Fig. 9C). The
results show that internalization of BSA/LLO-beads is dynamin-
dependent and clathrin-independent.
F-actin remodeling is induced by LLO in a pore-
dependent fashion and is required for bead
internalization
Internalization of large particles such as bacteria generally
requires the rearrangement of subcortical F-actin to form
membrane extensions that engulf the particles [57]. Consistent
with this idea, the membrane rearrangements observed by
scanning electron microscopy (Fig. 8A) were accompanied by
the recruitment of F-actin at the bead entry site (Fig. 9D).
Furthermore, bead entry was inhibited in cells treated with the F-
Figure 6. Characterization of the LLO variants. (A) Hemolytic activity of LLO, LLOmL, and LLOpL was measured at pH 7.4, 37uC. DTT =
dithiothreitol. (B) LLO, LLOmL, and LLOpL were incubated with erythrocyte ghost membranes, in the presence or absence of DTT, washed and
suspended in 1% detergent. The samples were subjected to gradient electrophoresis, in the presence of 1% detergent, and LLO was detected by
western blotting using anti-LLO antibodies. (C) Toxins were incubated for 1 h on cholesterol/DOPC lipid layers in the presence or absence of DTT. The
samples were processed and analyzed by transmission electron transmission microscopy. Scale bar=50 nm.
doi:10.1371/journal.ppat.1002356.g006
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PLoS Pathogens | www.plospathogens.org 8 November 2011 | Volume 7 | Issue 11 | e1002356Figure 7. Formation of pore complexes is required for efficient bacterial and bead entry into HepG2 cells. (A) LLO-deficient L.
monocytogenes (Dhly, L.m.) were treated with coating buffer in the absence (white bars, C), or presence of LLO, LLOmL, or LLOpL. Cells were infected
at 37uC for 30 min (MOI=20). Samples were washed, fixed, and fluorescently labeled to enumerate bacterial entry by fluorescence microscopy.
Results were the mean 6 SEM (n$3). (B) and (C) HepG2 cells were incubated with BSA- (Control; C) or BSA/toxin (LLO, LLOmL, or LLOpL)-coated
beads for 30 min at 37uC (MOI=20). Cells were washed, fixed, and labeled to enumerate bead entry (B) and association (C) by fluorescence
microscopy. Results were the mean 6 SEM (n$3). (D) HepG2 cells were incubated with BSA/LLO-coated beads for 30 min at 37uC, in the presence or
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integrity was not required for entry (Fig. 9E). F-actin remodeling
involves the activation of the host signaling machinery. As a first
approach to determine the transducers involved in entry, we have
treated cells with inhibitors of tyrosine kinases (genistein) and
phosphoinositide 3-kinases (PI3Ks) (LY294002 and wortmannin).
Tyrosine kinases and PI3Ks are key transducers activated
upstream from actin polymerization at the L. monocytogenes entry
site [13]. We found that only tyrosine kinase(s) activation was
critical for LLO-dependent entry (Fig. 9E). We also observed that
purified LLO induces membrane ruffling in the 0.5 to 2 nM
concentration range (representative Videos S6 and S7). Mem-
brane ruffling started 117614.3 sec after the addition of 1.2 nM
LLO and was optimal for 5556145 sec (calculated from 10
movies). This provided a convenient experimental model to
determine whether pore formation and tyrosine kinases were
involved in F-actin polymerization induced by LLO. LLO-
induced membrane ruffling was F-actin- and tyrosine kinase-
dependent as no ruffling was observed in cells stimulated by LLO
in the presence of 0.5 mg/ml cytochalasin D or 250 mM genistein
(Videos S8 and S9). Importantly, membrane ruffling was only
induced by LLO, but not by 0.5 to 50 nM LLOpL (Video S10).
These data provide a link between membrane perforation by LLO
and the remodeling of the F-actin cytoskeleton.
Discussion
These studies revealed the existence of a novel pathway
exploited by L. monocytogenes to gain entry into host cells. This
pathway is activated in response to membrane perforation by the
pore-forming toxin listeriolysin O (LLO). This is the first
demonstration that a pore-forming toxin is able to induce the
internalization of a bacterial pathogen into host cells. We have
used several approaches to show that LLO is crucial for efficient
entry of L. monocyogenes into HepG2 and HeLa cells and have used
beads coated with LLO to specifically decipher the molecular
machinery underlying this novel pathway.
LLO is known to mediate L. monocytogenes escape from the
endocytic vesicle following bacterial internalization into host cells
[27]. The present findings demonstrate that LLO is also critical for
L. monocytogenes internalization. Moreover, they show that LLO is
sufficient to induce bacterial entry. A role for LLO in bacterial
entry into nonphagocytic cells was previously proposed [35],
whereas other studies did not identify such a role for LLO [58]. All
of these studies relied upon the gentamicin survival assay that
measures intracellular survival. The gentamicin assay is a powerful
method, but it exhibits some limitations. First, it reports several
stages of the host cell invasion process and cannot distinguish the
role of LLO in bacterial entry from its role in intracellular survival.
Second, LLO perforates host cells and likely allows gentamicin
entry into the cells. As a result, the intracellular survival of WT L.
monocytogenes is underestimated in comparison to a LLO-deficient
mutant. In the gentamicin assay performed in the present study, a
low MOI (20) was used as higher amounts of bacteria led to
substantial entry of gentamicin into the cells (MW 480), as
reported by the incorporation of the cell impermeant dye ethidium
homodimer (MW 857) (our unpublished data). Therefore, we
developed an automated fluorescence-based assay to specifically
and accurately measure bacterial association and entry [48]. With
this approach, we demonstrate that LLO plays a critical role in
bacterial entry, but not in bacterial association with host cells.
Similar to LLO, we found that InlA and InlB did not significantly
affect bacterial association, but affected bacterial intracellular
survival and entry. This result is not surprising due to the
abundance of adhesins expressed by L. monocytogenes, as over ten
surface adhesins have been identified [31,59–65]. When overex-
pressed, LLO significantly increased L. monocytogenes association
with host cells. This result is in accordance with the observation
that LLO promotes Bacillus subtilis attachment to epithelial cells
[66]. LLO and other CDCs were also shown to remain partially
bound to the bacterial cell wall [67,68]. Therefore, when
overexpressed, the cell wall-associated toxin likely anchors the
bacteria to host cells via binding to membrane cholesterol. Indeed,
LLO is well known to bind to cholesterol in biological and artificial
membranes [40,69].
Our study focused on elucidating the role of LLO in bacterial
entry into host cells. We first investigated whether host cell
perforation by LLO was required for activating this entry pathway.
Although pore-formation by LLO is pH-sensitive at 37uC, we
demonstrated that extracellular LLO perforates host cells at neutral
pH. This finding is supported by a previous study that also
concluded that LLO is active at neutral and slightly basic pH values
[69]. We constructed LLO variants to determine if LLO binding to
host membranes, its oligomerization into a prepore complex, and
pore formation are required for LLO-induced bacterial entry. The
LLO variant unable to undergo the prepore to pore transition
demonstrated that the formation of LLO pore complexes is a key
event for bacterial and bead internalization into host cells. How
does pore-formation by LLO stimulate bacterial or bead uptake?
The LLO entry pathway appears to be distinct from the canonical
bacterial entry pathways. Bacteria are known to induce their entry
by activating host receptorsorby injectingeffectors into the host cell
cytosol [1,2,70]. Gram-positive bacteria do not have a type III
secretion system, although, they can produce CDC toxins to
mediate the translocation of virulence factors [71,72]. The
observation that LLO alone was sufficient to induce bacterial or
bead entry ruled out this mechanism. The requirement for
membrane perforation does not favor the simple model in which
LLO acts by activating a signaling host receptor. Indeed, the
LLOpL variant that binds to host cells and is able to rearrange into
a prepore complex failed to induce bacterial entry. Also, another
pore-forming toxin, PLY, could replace LLO in that function. We
do not rule out the existence of a yet unknown receptor for LLO
that would be shared by PLY, nevertheless, membrane perforation
remains a key trigger for entry.
LLO induces the formation of internalization vesicles that
accommodate large particles (bacteria or 1 mm beads) via a
cholesterol-, dynamin-, and F-actin-dependent, but clathrin-
independent pathway. Several clathrin-independent and dyna-
min-dependent internalization pathways have been described
absence (C) of LLO-neutralizing or control antibodies. Cells were washed, fixed, and fluorescently labeled. Bead entry was measured by fluorescence
microscopy and the results, mean 6 SEM (n$3) were expressed relative to the control (C). (E) Representative LLO hemolytic curves in the presence or
absence (No Ab) of the neutralizing or control antibodies (10 mg/ml) were performed at pH 7.4, 37uC. (F) Control (C), cholesterol-depleted and -
repleted HepG2 cells were incubated with BSA/LLO-coated beads for 30 min at 37uC. Bead entry was measured by fluorescence microscopy and the
results, mean 6 SEM (n$3) were expressed relative to the control. (G) Control (C), cholesterol-depleted and -repleted HepG2 cells were incubated
with various concentrations of LLO, 0.2% TX-100, or MEM (Control) at 37uC for 30 min. LDH release was measured using the TOX7 assay kit. Results
are the mean 6 SEM (n$3).
doi:10.1371/journal.ppat.1002356.g007
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PLoS Pathogens | www.plospathogens.org 10 November 2011 | Volume 7 | Issue 11 | e1002356Figure 8. LLO-coated beads are internalized into EEA1 positive endosomes. (A) HepG2 cells were incubated at 37uC with BSA/LLO-coated
beads for 15 or 30 min, washed, fixed, and processed for scanning electron microscopy analysis. Scale bar=1 mm. (B) HepG2 cells were incubated for
30 min at 37uC with BSA/LLO-coated beads, washed, fixed, and the extracellular beads were labeled with anti-BSA antibodies and a fluorescent
secondary antibody (red). After permeabilization, EEA1 was labeled using anti-EEA1 antibodies and a fluorescent secondary antibody (green). Scale
bar=10 mm. PC = phase contrast. Arrows point out internalized beads and the arrowhead an internalized bead that massively recruited EEA1. (C)
Results were expressed as the mean 6 SEM (n$3) percentage of intracellular beads that recruited EEA1.
doi:10.1371/journal.ppat.1002356.g008
Host Cell Perforation as a Novel Invasive Strategy
PLoS Pathogens | www.plospathogens.org 11 November 2011 | Volume 7 | Issue 11 | e1002356Host Cell Perforation as a Novel Invasive Strategy
PLoS Pathogens | www.plospathogens.org 12 November 2011 | Volume 7 | Issue 11 | e1002356including lipid raft-dependent pathways [73]. It is important to
note that the role of cholesterol in this pathway might be complex,
as cholesterol is a structural component of lipid rafts and is critical
for LLO binding to host membranes and the formation of LLO
pores. However, the observation that LLO associates with and
induces the coalescence of lipid raft microdomains favors the
hypothesis of a lipid raft-mediated pathway [74]. We found that
LLO induces the polymerization of actin at the bead entry site,
and that F-actin dynamics and tyrosine kinase activation are
required for LLO-mediated bead entry. Using soluble LLO and
LLOpL, we observed that membrane perforation by LLO induces
F-actin-dependent membrane ruffling. Interestingly, F-actin poly-
merization within membrane ruffles was tyrosine kinase-depen-
dent. Together, our findings support a model in which host cell
perforation by LLO leads to an internalization pathway that
involves host tyrosine kinase-dependent stimulation of the actin
cytoskeleton and the activity of dynamin. Similar to LLO, PLY
promoted bacterial entry into host cells and was shown to induce
actin polymerization in neuroblastoma cells [75].
T h ef a c tt h a tL L Oi n d u c e si n t e r n a l ization of bacteria in a pore-
dependent fashion is reminiscent of the membrane repair pathway
observed in eukaryotic cells exposed to pore-forming toxins. In
response to the attack by pore-forming proteins, eukaryotic cells
undergo membrane endocytosis to remove the pores from their
plasma membranes [45,47]. We identified host cell effectors, F-actin
and dynamin, that are required for LLO-induced particle internal-
ization but are dispensable for membrane repair (Fig. S6) [45]. In
conclusion, membrane repair is likely a prerequisite for LLO-induced
bacteria/bead entry, but the LLO-mediated entry pathway extends
beyond or is distinct from the membrane repair pathway.
The mechanisms evolved by L. monocytogenes to gain entry into
nonphagocytic cells are complex and involve several invasins such as
I n l A ,I n l B ,a n dL L O .T h einlA, inlB,a n dhly genes are controlled by
the central regulator of virulence genes, PrfA, and are highly up-
regulated in vitro and in vivo during L. monocytogenes infection [76,77].
Therefore, LLO is expressed together with InlA and InlB to mediate
host cell invasion. Depending on the receptors expressed by host cells,
InlA and InlB stimulate bacterial entry individually or in concert
[13,21]. LLO likely affects bacterial internalization in a large panel of
cells because its major host receptor is cholesterol. We used
hepatocytes (HepG2 cells) that express the InlA and InlB receptors,
E-cadherin and the HGF-Rc, respectively [78,79]. We also used
HeLa cells that do not express E-cadherin and are only permissive to
the InlB entry pathway [30]. Our results showed that LLO played a
critical role in L. monocytogenes internalization into both cell lines.
Therefore, LLO cooperation with InlB alone or with InlA and InlB is
critical for bacterial internalization. Our study on LLO and previous
studies on InlA and InlBshowed that thesemolecules are individually
sufficient to induce bacterial entry with high efficiency when
overexpressed from a plasmid or coated on beads [17,20,80].
However, the expression level of these molecules is low in L.
monocytogenes and their concerted activity likely ensures efficient
bacterial uptake by host cells. The literature shows that most stages in
the infectious lifecycle of a pathogenic bacterium involve numerous
factors, all working in concert [21,81,82]. A recent study demon-
strated the importance of the cooperation between InlA and InlB
during L. monocytogenes entry into host cells [21]. In this study it was
shown that InlA ensured the specificity of bacterial recognition of
intestinal cells, whereas InlB increased the InlA internalization rate.
Likewise, we speculate that cooperation between LLO, InlA, and
InlB occurs during host cell invasion. In this model, the three
pathways would contribute simultaneously to the uptake of a given
bacteria. Given the identified roles of LLO, InlA, and InlB in
stimulating actin polymerization and endocytosis, cooperation
between the three invasins likely involves both of these processes.
The LLO-dependent entry pathway displays differences and
similarities with the InlA and InlB pathways. They differ with respect
to the mechanism used to activate the host cells, as membrane
perforation is required in the LLO but not in the InlA and InlB
pathways. Also, clathrin is involved in the InlA and InlB pathways
[83], but not in the LLO pathway. However, the internalization
induced by the three invasins shares common effectors such as host
tyrosine kinases,dynamin, cholesterol, and F-actin[13]. Determining
how host cells integrate the signals simultaneously generated by each
invasin and whether the resulting pathway is the sum of the individual
pathways or is a new pathway leading to efficient bacterial uptake
constitutes an important goal for future research.
Pore-forming toxins are produced by numerous pathogens and
may influence their uptake by host cells [84,85]. In favor of this
hypothesis, while this work was under revision, it has been
published that the parasite Trypanosoma cruzi invades host cells by
exploiting a host cell membrane repair mechanism in response to
membrane damage [86]. Among CDC-producing bacteria, the
genera Listeria, Arcanobacterium, Bacillus, and Streptococcus include
several pathogenic bacteria that have been shown to invade
nonphagocytic cells [87–92]. Interestingly, the CDC intermedily-
sin (ILY) is required for internalization of Streptococcus intermedius
[88]. However, not all of the CDCs share this property, as a recent
study showed that streptolysin O (SLO) inhibits internalization of
Group A Streptococcus into keratinocytes [93]. Therefore, a
fascinating avenue of research is to elucidate the molecular
mechanisms underlying the role of pore-forming toxins in the
regulation of host cell invasion by intracellular pathogens.
Materials and Methods
Bacterial strains and plasmids
WT L. monocytogenes (DP10403S), isogenic Dhly (hly is the gene
coding for LLO) (DPL2161), and DinlAB (DPL4404) deletion
mutants were gifts from Dr. Dan Portnoy (U.C. Berkeley,
Figure 9. LLO-coated beads are internalized by a clathrin-independent, dynamin-, F-actin- and tyrosine kinase-dependent
pathway. (A) to (C) Clathrin heavy chain was knocked down in HepG2 cells by siRNA (siRNACHC) treatment or was inhibited by pre-incubating the
cells for 30 min with 10 mM chlorpromazine (CPZ). Dynamin was inhibited by pre-incubating the cells for 30 min with 120 mM dynasore (DY). CPZ and
DY were maintained in the cell culture medium throughout the experiments. (A) HepG2 cells were incubated with BSA/LLO-coated beads for 30 min
at 37uC. Cells were washed, fixed, and bead entry was enumerated. Results were the mean 6 SEM (n$3) and were expressed relative to the control
(C). (B) Representative western blot analysis of clathrin heavy chain (CHC) in cells treated with scrambled siRNA (siRNAc), specific siRNA (siRNACHC), or
control untreated cells (C). The a-tubulin was used as a loading control. (C) Measurement of internalized transferrin (Tf)/Surface associated (Tf) and
internalized (Tf) in control untreated cells (C), cells treated with siRNAc or siRNACHC, and cells treated with CPZ or DY. Only internalized (Tf) was
measured in DY-treated cells due to DY fluorescence. Representative experiments (of 3) are shown. (D) HepG2 cells were incubated for 30 min with
BSA/LLO-coated beads, fixed, and extracellular beads were labeled using anti-BSA antibodies and secondary fluorescent antibodies (red) and F-actin
was labeled with fluorescent phalloidin (green). Scale bar=5 mm, PC = phase contrast. The arrowhead and arrows point out extracellular and
internalized beads, respectively. (E) HepG2 cells were pre-incubated in the presence or absence of cytochalasin D (CD), nocodazole (NO), genistein
(GEN), LY294002 (LY), or wortmannin (W) at 37uC. Beads were added for 30 min in the presence of the inhibitors. The percentage of internalized
beads was enumerated by fluorescence microscopy and the results were the mean 6 SEM (n$3).
doi:10.1371/journal.ppat.1002356.g009
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(Dhly DinlAB) we deleted hly in the DPL4404 strain by allelic
exchange using the pKSV7 integrational shuttle vector (a gift from
Dr. Nancy Freitag, University of Illinois at Chicago, USA) [97]. A
,1000-bp DNA fragment consisting of the upstream (from bp 962
to 1463) and downstream (from bp 3029 to 3529) sequences
flanking the hly open reading frame was amplified from L.
monocytogenes chromosomal DNA [96]. The primers (Table S1)
were designed to generate restriction sites for EcoRI and PstI. The
digested fragment was ligated into pKSV7. The pKSV7 with the
1000 bp fragment was used to perform allelic exchange according
to [98]. Nonhemolytic colonies were identified on 5% blood agar
plates (Becton Dickinson). The deletion of hly was further ensured
by amplification of the chromosomal DNA with the primers used
to generate this strain and a second set of primers that amplify the
entire hly coding region. WT LO28 L. monocytogenes and the
isogenic transposon insertion LO28 hly::Tn917 mutant were gifts
from Dr. Pascale Cossart (Pasteur Institute, Paris, France) [99]. L.
innocua 33090 was purchased from ATCC. Bacteria were grown
overnight at 37u C in brain heart infusion (BHI) (BD Biosciences).
For invasion assays, overnight cultures were diluted 1/20 in BHI
and grown at 37uC until OD600=0.7–0.8. Bacteria were washed
three times in phosphate-buffered saline (PBS) and diluted to the
indicated multiplicity of infection (MOI) in the cell culture
medium without serum. The plasmids pAM401 and pET29b
coding for hly were gifts from Dr. D. Portnoy (Jones and Portnoy
1994). The plasmid phly/prfA* coding for hly was a gift from Dr.
Svetlana A. Ermolaeva (Gamaleya Research Institute of Epide-
miology and Microbiology, Moscow, Russia)[100]. The plasmid
pQE-30 coding for ply was kindly provided by Dr. R. K. Tweten
[40].
Mammalian cell cultures
Human hepatocyte (HepG2 cells, ATCC HB-8065) and
cervical epithelial (HeLa, ATCC CCL-2) cell lines were grown
in minimum essential medium (MEM) (+) Earle’s salts and L-
glutamine (Invitrogen), supplemented with 10% heat inactivated
fetal bovine serum (HI-FBS; Lonza), 0.1 mM nonessential amino
acids, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 mg/
ml streptomycin (Invitrogen). Mammalian cells were maintained at
37uCi n5 %C O 2 atmosphere. Cells were seeded in 24-well tissue
culture plates and grown for 48 h (HepG2; 1610
5 cells/well) or
24 h (HeLa; 0.5610
5 cells/well) before infection.
Coating of bacteria and polystyrene beads with LLO
Bacteria were coated with six-His-tagged toxin [49]. Briefly,
4610
8 bacteria were washed twice and incubated for 10 min on
ice in buffer A (20 mM Hepes pH 7.5, 50 mM NaCl, 1 nM nickel
chloride). Bacteria were washed and incubated in 200 ml buffer B
(20 mM Hepes pH 7.5, 50 mM NaCl) for 10 min with six-His-
tagged toxin. Bacteria were then washed once with buffer B and
suspended in 200 ml of buffer C (20 mM Hepes pH 7.5, 150 mM
NaCl) before infecting HepG2 cells. Carboxylate microspheres
(Alexa 350, 1 mm diameter; Molecular Probes) were covalently
coated with 5 mg/ml bovine serum albumin (BSA) following the
manufacturer’s instructions. LLO was noncovalently associated to
the surface of the BSA coated beads using the same experimental
procedure used to coat bacteria. In each experiment, we verified
that host membranes were not damaged by LLO, as this could
cause the entry of antibodies used to label extracellular bacteria.
Following fixation, cells were labeled with an anti-tubulin antibody
(Sigma) and secondary fluorescent antibodies. We observed that in
our experimental conditions antibodies could not enter the cells as
microtubules were not labeled.
Gentamicin survival assay
HepG2 cells were infected with the L. monocytogenes strains at
MOI 20, LLO-coated bacteria at MOI 20, or L. innocua and L.
innocua phly/prfA* at MOI 100. The plates were centrifuged at
room temperature for 5 min and incubated for 30 or 60 min at
37uC. Cells were washed and incubated with 15 mg/ml (for
bacteria grown to OD600=0.8) or 100 mg/ml (For L. innocua
grown to OD600=0.2) gentamicin for 1 h or 30 min, respectively.
When measuring the intracellular survival of L. innocua in
comparison to L. innocua phly/prfA*, the bacteria were grown to
OD=0.2 because this bacterial density led to the highest secretion
levels of LLO (data not shown). Cells were washed three times with
PBS and lysed with 0.2% Triton X-100 in H2O. Serial dilutions of
cell lysates were immediately performed in PBS and plated on BHI
agar. The colony forming units (CFUs) were enumerated after
48 h of incubation at 37uC.
Measurement of bacterial association and entry into host
cells
HepG2 cells (or HeLa cells) were infected with bacteria at MOI
20. The plates were centrifuged for 5 min (230 x g) at room
temperature and incubated for 30 min at 37uC. Cells were washed
with PBS, fixed with PBS/4% paraformaldehyde (PFA) for 15 min
at room temperature, and then washed with 0.1 M glycine in PBS
and incubated for 1 h in blocking solution (0.1 M glycine, 10% HI-
FBS in PBS, pH 7.4)Following fixation and blocking, extracellular
bacteria, total bacteria and host cells were labeled as previously
described [48]. To quantitate the numbers of bacteria and
mammalian cells, 40 sets of images (DAPI, Alexa 488, Alexa 568,
phase contrast) were automatically acquired for each experimental
condition using a 20 X objective. MetaMorph imaging and analysis
software was used to enumerate the total number of bacteria (Nt),
extracellular bacteria (Ne), and mammalian cells (Nc) [48]. The
percentage of internalization was calculated as (Nt - Ne)/Nt x 100.
Bacterial association with host cells was calculated as Nt/Nc. The
results were expressed relative to control (% control). For invasion
assays in the presence of soluble LLO, LLO was added to the cell
culture medium along with L. monocytogenes.
Construction and purification of recombinant toxins
LLO variants were constructed by PCR-based site-directed
mutagenesis using pET29b encoding native six-His-tagged LLO as
a template. Mutagenic primers (Table S1) were used to construct
LLOmL containing the substitutions K344C and I359C; LLOpL
containing the substitutions G80C and S213C; and LLO Alexa
488 with the substitutions C484A and D69C. Mutations were
introduced by amplifying hly from pET29b using pfu Ultra II
fusion polymerase, followed by digestion of methylated template
DNA by DpnI (Stratagene). The constructs were transformed in E.
coli XL1-Blue and BL21(DE3). Mutations were confirmed by
DNA sequence analysis at The Ohio State University Plant-
Microbe Genomics Facility. Recombinant six-His-tagged LLO
and PLY were purified from E. coli BL21(DE3) as described
previously [101]. LLOmL and LLOpL were dialyzed overnight in
the absence of reducing agents to allow for disulfide bond
formation. Toxins were stored at 280uC in 1 M NaCL, 50 mM
phosphate buffer, pH 8. To obtain LLO Alexa 488, LLOC484A/
D69C was labeled by chemical coupling to Alexa 488-Maleimide
(Molecular Probes) under conditions that lead to a dye to protein
molar ratio .0.9, following the manufacturer’s instructions. The
fluorescent toxin was separated from the unconjugated dye by gel
filtration chromatography. All the recombinant toxins purified in
this study contain a six His tag.
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Sheep erythrocytes (10% suspension; Lampire Biological) were
diluted to 0.25% in PBS pH 7.4. Serial dilutions of toxins and
erythrocytes were co-incubated in PBS at 37uC for 30 min in 96
well plates. Plates were centrifuged and the absorbance of the
supernatant (A540) was measured in a PowerWavex340 spectro-
photometer. Erythrocytes incubated with 0.1% Triton X-100 in
PBS or PBS alone served to determine the maximum (100%) and
minimum (0%) hemolytic activity, respectively. DTT alone had no
effect on hemolysis (data no shown). The hemolytic activities of the
bacteria were measured using a similar approach except that the
indicated amounts of bacteria were added to the wells. The kinetic
hemolytic assay in Fig. 5 was performed according to [102]. In this
assay a decrease in absorbance reflects the lysis of erythrocytes.
Western blotting analysis of LLO expression by the
bacterial strains
Overnight cultures of L. monocytogenes, L. innocua, and L. innocua
phly/prfA* were diluted 1/20 in BHI and grown to OD600=0.8 (L.
monocytogenes)o rO D 600=0.2 (L. innocua, and L. innocua phly/prfA*)
in BHI. Bacterial suspensions containing 2.0610
8 bacteria were
collected and centrifuged. The supernatants were collected for
protein precipitation and bacterial pellets were washed and lysed
as follows. The supernatants (0.25 ml of L. monocytogenes and 1 ml
of L. innocua cultures) were subjected to trichloroacetic acid (TCA)
precipitation. One volume cold TCA was added to 4 volumes of
supernatant and incubated 1 h on ice. Samples were centrifuged
(11,000 g, 10 min, 4uC) and precipitates were washed twice with
cold acetone. Bacterial and dried protein pellets were suspended in
Laemmli’s sample buffer. Bacterial lysates (10
7 bacteria/well,
,600 ng/well) and precipitates were subjected to SDS-PAGE and
western blotting using rabbit anti-LLO (Abcam) and horseradish
peroxidase-conjugated secondary antibodies (Cell Signaling).
HepG2 perforation assay
HepG2 cells (0.5610
5) were cultured in glass bottom culture
dishes (MatTek; 35 mm petri dish, 10 mm microwell) for 48 h.
Cells were washed twice and incubated in the presence or absence
of 1 mM CaCl2 in a buffer containing 150 mM NaCl, 1 mM
MgCl2, 5 mM KCL, 20 mM Hepes, 10 mM Glucose, 4 mM
ethidium homodimer, pH 7.4. Cells were placed on a temperature
controlled microscope at 37uC and phase-contrast and fluores-
cence images were recorded every 10 s using a 100 X objective for
10 min. LLO (0.5 nM) was added and movies were recorded for
an additional 28 min. Results were expressed as the average
fluorescence intensity measured from at least 5 movies at each
time point.
LDH and cell viability measurements
HepG2 cells were incubated with LLO (1, 5, or 20 nM) or
BSA/LLO-coated beads for 30 min at 37uC. Following incuba-
tion, supernatants were recovered from each sample and
centrifuged at 500 x g at 4uC for 5 minutes to pellet any cells
released into the supernatant. 10 ml of each supernatant was
diluted into 40 ml of cell culture medium without serum in 96 well
plates, and assayed for the presence of lactate dehydrogenase with
the TOX7 in vitro toxicology assay kit according to the
manufacturer’s instructions (Sigma). To assess cell viability
immediately or 24 h after LLO treatment, HepG2 cells were
detached from wells with 0.25% Trypsin-EDTA. Cells were then
mixed 1:1 with 0.4% trypan blue for 3 minutes, after which viable
(unstained) and nonviable (stained in blue) cells were enumerated
with a hemocytometer.
Toxin oligomerization (NativePAGE)
Erythrocyte ghost membranes (EGM) were prepared as
described previously [44] and stored at 4uC in resealing buffer
(10 mM phosphate buffer, 5 mM MgCl). EGM (6.75610
8) were
incubated in PBS with 157 nM LLO on ice for 1 min and were
transferred to 37uC for 5 min. When indicated, 4 mM DTT was
added to reduce the disulfide bond in LLOmL and LLOpL.
Samples were centrifuged at 15,000 x g for 15 min and the
supernatant was removed and replaced with an equal volume of
PBS. LLO oligomerization was analyzed using the NativePAGE
Novex Bis-Tris Gel electrophoresis system. The samples were
mixed with NativePAGE sample buffer containing 1% detergent,
and run on a 4–16% Bis-Tris gel as described by the manufacturer
(Invitrogen). LLO was detected by western blotting.
Toxin oligomerization (transmission electron microscopy)
LLO solutions (750 nM) in buffer (20 mM Hepes, pH 7.0,
62 mM DTT) were pipetted in Teflon wells as 13 ml droplets and
coated with 1 ml of a 0.5 mg/ml lipid mixture containing
50 mol% cholesterol (Avanti) and 50 mol% 1,2 dioleoyl-sn-
glycero-3-phosphocholine (Avanti) in chloroform. After incubation
in a humid chamber at room temperature for 1 h, the LLO
complexes were transferred to carbon support films on electron
microscopy (EM) grids and negatively stained with 1% (w/v)
uranyl acetate and observed with a FEI Tecnai F20 transmission
electron microscope equipped with a Gatan Ultrascan 4K X4K
CCD camera.
Invasion assays using polystyrene beads, F-actin and
EEA1 labeling
Cells were washed and incubated for 30 min with BSA-, or
BSA/LLO-coated beads at a MOI=20 in MEM. Cells were
washed, fixed with PFA and blocked. Extracellular beads were
labeled with an anti-BSA rabbit polyclonal antibody (Sigma)
followed by a goat anti-rabbit secondary antibody conjugated to
Alexa-568. The percentage of internalized beads was determined
by fluorescence microscopy based on their unique (Alexa 350,
intracellular) or dual fluorescence (Alexa 350 + Alexa 568,
extracellular) and expressed as% intracellular beads (= intracel-
lular beads/total beads * 100). EEA1 was labeled with a primary
antibody (Santa Cruz) and a fluorescent (Alexa 488) donkey anti-
goat secondary antibody in permeabilized cells. When co-labeling
of the BSA beads and EEA1 was performed, a fluorescent donkey
anti-rabbit secondary antibody was used to label the primary
rabbit anti-BSA antibody. For F-actin labeling, cells were fixed
and labeled as described in [102].
Silencing of clathrin heavy chain in HepG2 cells
HepG2 cells were transfected in 24 well cell culture plates with
specific human clathrin heavy chain siRNA (Ambion 43908824,
Table S1) or with scrambled siRNA (Ambion, 4390843) (50 nM
siRNA in 0.5 ml/0.5610
5 cell/well) using SiPort neoFx transfec-
tion reagent according to the manufacturer instructions (Ambion).
After 24 h, cell culture medium was replaced and cells were
further incubated for 24 h. Clathrin knock-down efficiency was
verified in each experiment by western blotting using primary
rabbit anti-clathrin heavy chain (Abcam) and mouse anti-a-tubulin
(Sigma) antibodies.
Cell treatment with chemical inhibitors
Cells were pre-incubated with 0.5 mg/ml cytochalasin D
(Sigma) for 10 min, 33 mM nocodazole (Sigma) for 60 min,
250 mM Genistein (Sigma) for 60 min, 37 mM LY294002 (EMD
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or 120 mM dynasore (Sigma) for 30 min, and 10 mM chlorprom-
azine (Sigma) for 30 min before the addition of coated beads, and
the drugs were maintained at the same concentrations in the cell
culture medium until the cells were fixed.
Transferrin uptake
HepG2 cells were washed three times in MEM and were serum
starved for 2 h. Cells were incubated in MEM at 37uC with 5 mg/
ml iron loaded Alexa 568 conjugated tranferrin (Molecular
Probes). After 2 and 10 min of incubation, cells were transferred
to ice, washed three times with cold medium and acid washed
(200 mM NaCl, 50 mM MES, pH5.0) for 5 min. Four washes
were performed with a cold buffer containing 150 mM NaCl,
1 mMCaCl2, 1 mM PBS, 5 mM KCl, 20 mM Hepes, pH 7.4.
Alexa 488-conjugated transferrin was added (5 mg/ml) for 2 h at
4uC. Cells were then washed and fixed. Phase contrast and
fluorescence images of the internalized (Alexa 568-Tf) and cell
surface-associated (Alexa 488-Tf) fluorescent transferrin were
acquired using a 40X objective. Extracellular and internalized
transferrin molecules were measured by quantitative fluorescence
microscopy. Briefly, images were first background corrected and
the average fluorescence intensities were measured in the cells
(about 1000 cells were analyzed for each experimental condition).
Cholesterol depletion and repletion and LLO treatment
with neutralizing antibodies
For cholesterol depletion, HepG2 cells were washed twice with
MEM (without serum) and incubated at 37uC for 30 min with
5m MM bCD in MEM. Cells were then washed twice and assayed
as described. For cholesterol repletion, cholesterol-depleted cells
were washed twice and incubated for 15 min with a solution of
5 mM cholesterol-MbCD in MEM, then washed and assayed as
described.
A 1:1:1 mixture of three monoclonal anti-LLO neutralizing
(H14-3, B8B20-3-2, and A4-8) or control anti-LLO (D21-1-4)
antibodies (gift from Dr. P. Cossart, Institute Pasteur, France) was
added to purified LLO or to BSA/LLO-coated beads at
concentrations of 2, 10, or 20 mg/ml.
Image acquisition
Images were acquired on a motorized inverted epi-fluorescence
microscope (Axio Observer D1, Zeiss) equipped with 20 X Plan
Neofluar (N.A.=0.5), 100 X Plan Apo (N.A.=1.4), and 40X Plan
Neofluar (N.A.=1.3) objectives, a high speed filter changer
Lambda DG-4 (300 Watts Xenon Arc bulb, Sutter Instrument
Company), an optical emission filter wheel Lambda 10–3 for the
fluorescence imaging, and a Smart shutter that controls the
illumination for phase contrast imaging (Sutter Instrument
Company). The camera (back-illuminated, frame-transfer
EMCCD Cascade II 512) was from Photometrics. The filter sets
for fluorescence were purchased from Chroma Technology
Corporation: DAPI (49000), GFP/FITC/Alexa488 (49002),
Cy3/DsRed/Alexa568 (49005). The microscope was controlled
by MetaMorph imaging software (Universal Imaging).
Live cell imaging
All movies were acquired on the microscope stage of an inverted
fluorescence microscope at 37uC using a 100X objective. Phase
contrast and fluorescence images of HepG2 cells were acquired
every 10 s for 40 min, LLO was added 10 min after starting
recording. In some experiments, cells were incubated in calcium-
free buffer as indicated. Movies were accelerated 198 times.
Scanning electron microscopy
Following incubation with BSA/LLO-coated beads, cells were
washed in PBS, fixed and processed as described in [23] with the
following modifications: Coverslips were sputter coated with gold
palladium at 17 mA for 75 sec with a Cressington 108 sputter
coater. Samples were examined and photographed with a FEI
Nova Nano scanning electron microscope operating at 5 Kv.
Statistics
A minimum of three independent experiments were performed,
each in duplicate, unless otherwise indicated. Data were expressed
as mean 6 Standard Error of the Mean (SEM). P-values were
calculated using a standard two-tailed Student’s t-test and
determined significant if lower than 0.05. In figures, asterisks
indicate a significant difference between the indicated experimen-
tal conditions (* p,0.05; ** p,0.005).
Accession numbers
The NCBI Reference Sequence (RefSeq) accession numbers for
the listeriolysin O gene and protein are as follows: hly
(NC_003210.1), LLO ( ZP_05237132).
Supporting Information
Figure S1 LLO is required for efficient entry of two L.
monocytogenes strains into HepG2 and HeLa cells. (A)
HepG2 and (B) HeLa cells were infected with WT (DP10403S or
LO28) and corresponding isogenic LLO-deficient (Dhly or
hly::Tn917) bacteria (MOI =20) for 30 min at 37uC. Cells were
washed, fixed, and labeled with fluorescent antibodies and DAPI.
Bacterial association and entry were expressed relative to WT
strains. Results were the mean 6 SEM (n$3).
(TIF)
Figure S2 L. monocytogenes coating with recombinant
LLO. (A) The hemolytic activity of LLO Alexa 488 and LLO was
measured in triplicate for 30 min at 37uC and pH=7.4. A
representative experiment (of 3) is presented. (B) LLO-deficient L.
monocytogenes (Dhly, DPL2161, L.m.) were coated with LLO Alexa
488 and the fluorescence intensity associated with bacteria was
measured by quantitative fluorescence microscopy. Results were
the average fluorescence intensity (A.F.I.) 6 SEM expressed in
arbitrary units (n$3). At least 100 bacteria were analyzed in each
experiment.
(TIF)
Figure S3 LLO-coated beads do not affect HepG2 cell
viability. (A) HepG2 cells were incubated for 30 min at 37uC
with BSA- or BSA/LLO-coated beads (MOI=20). LDH released
into the supernatant was measured immediately after treatment.
As controls, we used untreated cells (control) and cells incubated
with 0.2% TX-100 for 30 min. Cell viability was assessed
immediately (B)o r2 4h( C) after treatment by counting viable
cells that excluded trypan blue. Results were the mean 6 SEM
(n$3).
(TIF)
Figure S4 LLO-coated beads form small pores in
HepG2 cells. HepG2 cells were incubated with BSA/LLO-
and BSA-coated beads for 30 min at 37uC. Cells were pulse
labeled with propidium iodide (100 mM) for 1 min, washed and
fixed to quantify the fluorescence associated with the cells. (A)
Representative DAPI and propidium iodide (PI) fluorescence
images were acquired with a 20X objective. (B) Quantification of
propidium iodide incorporation into the cells. Results represent
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were the mean 6 SEM (n$3).
(TIF)
Figure S5 PLY induces L. monocytogenes entry into
HepG2 cells. (A) Hemolytic activity of LLO and PLY measured
after 30 min at 37uC, pH=7.4. A representative experiment (of 3)
is presented. (B) HepG2 cells were incubated for 30 min at 37uC
with LLO-deficient L. monocytogenes incubated in coating buffer in
the presence or absence of 1 mM LLO or PLY. Bacterial
internalization was measured by fluorescence microscopy. Results
were expressed as the mean 6 SEM (n$3).
(TIF)
Figure S6 F-actin, dynamin, and clathrin are dispens-
able for the membrane repair pathway. HepG2 cell
perforation was measured by quantitative live cell fluorescence
microscopy. Cells were incubated on the microscope stage at 37uC
for 30 min with 20 mg/ml propidium iodide (a cell impermeant
nuclear dye) in the presence or absence (Ca
2+ free medium) of 1 mM
extracellular calcium. When inhibitors were used, cells were pre-
incubated at 37uC with 10 mM chlorpromazine (CPZ), 160 mM
dynasore (DY) for 30 min or 0.5 mg/ml cytochalsin D (CD) for
10 min and the inhibitors were maintained throughout the duration
of the experiments. Phase contrast and fluorescence images were
recorded at regular time intervals using a 100X objective. LLO
(1.2 nM)was addedafter 5 min of incubation. Results were expressed
as the average fluorescence intensity (in arbitrary units) in the cells 6
SEM of 5 to 10 movies for each experimental condition.
(TIF)
Table S1 Primer and siRNA sequences used in this
study.
(RTF)
Video S1 Phase contrast movie of HepG2 cells incubat-
ed in calcium-free medium.
(AVI)
Video S2 Fluorescence movie of HepG2 cells incubated
in calcium-free medium.
(AVI)
Video S3 Phase contrast movie of HepG2 cells exposed
to 0.5 nM LLO in calcium-free medium.
(AVI)
Video S4 Fluorescence movie of HepG2 cells exposed to
0.5 nM LLO in calcium-free medium.
(AVI)
Video S5 Phase contrast movie of HepG2 exposed to
0.5 nM LLO in calcium-free medium in the absence of
ethidium homodimer.
(AVI)
Video S6 Phase contrast movie of HepG2 cells exposed
to 0.5 nM LLO.
(AVI)
Video S7 Phase contrast movie of HepG2 cells exposed
to 1.2 nM LLO.
(AVI)
Video S8 Phase contrast movie of HepG2 cells exposed
to 0.5 nM LLO + 0.5 mg/ml cytochalasin D.
(AVI)
Video S9 Phase contrast movie of HepG2 cells exposed
to 1.2 nM LLO and 250 mM genistein.
(AVI)
Video S10 Phase contrast movie of HepG2 cells exposed
to 10 nM LLOpL.
(AVI)
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